Related Experiment Video
Updated: May 7, 2026

Detecting Migration and Infiltration of Neutrophils in Mice
Published on: February 6, 2020
Decreased PERP expression on peripheral blood mononuclear cells from patient with rheumatoid arthritis negatively
1The First Hospital of Xiamen University, Xiamen 361003, China.
Background:
PERP, p53 apoptosis effector related to PMP-22, is a p53-dependent apoptosis in diverse cell types and has cell type-specific roles in p53-mediated apoptosis. However, its role in PBMCs of RA patients has remained largely unclear.
Objectives:
The aim of this study was to detect the expression levels of PERP on PBMCs of RA patients and healthy controls and analyze the role of PERP in the pathogenesis of RA. Methods. The mRNA expression levels of PERP and IL-17 were detected by real-time PCR in PBMCs from patients with RA (n = 40) and healthy controls (n = 40). The correlations of PERP expression levels to IL-17 transcripts and disease activity parameters were analyzed.
Results:
The PERP and IL-17 expression levels in the PBMCs were significantly decreased and increased in comparison of which in healthy controls. The mRNA expression levels of PERP in PBMCs from patients with RA were negatively correlated with IL-17 and disease activity parameters DAS28, RF, CRP, and ESR rather than Anti-CCP and ANA.
Conclusions:
These results demonstrated that PERP might be involved in the pathogenesis and a potential therapeutic target of RA by regulating the expression of IL-17.
Insights
PERP expression is decreased in rheumatoid arthritis (RA) patients, while IL-17 is increased. PERP may be a therapeutic target for RA by regulating IL-17.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- PERP (p53 apoptosis effector) plays a role in p53-mediated apoptosis.
- Its function in peripheral blood mononuclear cells (PBMCs) of rheumatoid arthritis (RA) patients is not well understood.
Purpose of the Study:
- To investigate PERP expression levels in PBMCs from RA patients and healthy controls.
- To analyze the role of PERP in RA pathogenesis, particularly its relationship with IL-17 and disease activity.
Main Methods:
- Real-time PCR was used to measure mRNA expression of PERP and IL-17 in PBMCs.
- Correlations between PERP levels, IL-17, and clinical disease parameters (DAS28, RF, CRP, ESR, Anti-CCP, ANA) were analyzed.
Main Results:
- PERP mRNA levels were significantly decreased in RA patients compared to healthy controls.
- IL-17 mRNA levels were significantly increased in RA patients.
- PERP expression negatively correlated with IL-17, DAS28, RF, CRP, and ESR.
Conclusions:
- PERP expression is altered in RA PBMCs.
- PERP may contribute to RA pathogenesis by influencing IL-17 levels.
- PERP represents a potential therapeutic target for RA.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies